Page last updated: 2024-09-04

glg-v 13 and 4-aminopyridine

glg-v 13 has been researched along with 4-aminopyridine in 1 studies

*4-Aminopyridine: One of the POTASSIUM CHANNEL BLOCKERS with secondary effect on calcium currents which is used mainly as a research tool and to characterize channel subtypes. [MeSH]

*4-Aminopyridine: One of the POTASSIUM CHANNEL BLOCKERS with secondary effect on calcium currents which is used mainly as a research tool and to characterize channel subtypes. [MeSH]

Compound Research Comparison

Studies
(glg-v 13)
Trials
(glg-v 13)
Recent Studies (post-2010)
(glg-v 13)
Studies
(4-aminopyridine)
Trials
(4-aminopyridine)
Recent Studies (post-2010) (4-aminopyridine)
8004,141134804

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Berlin, KD; Fazekas, T; Iost, N; Lazzara, R; Pap, JG; Scherlag, BJ; Varró, A; Virág, L1

Other Studies

1 other study(ies) available for glg-v 13 and 4-aminopyridine

ArticleYear
Effect of GLG-V-13, a class III antiarrhythmic agent, on potassium currents in rabbit ventricular myocytes.
    Life sciences, 2000, Volume: 66, Issue:17

    Topics: 4-Aminopyridine; Animals; Anti-Arrhythmia Agents; ATP-Binding Cassette Transporters; Bridged Bicyclo Compounds, Heterocyclic; Heart; Imidazoles; In Vitro Techniques; KATP Channels; Myocardium; Potassium Channels; Potassium Channels, Inwardly Rectifying; Potassium Channels, Tandem Pore Domain; Rabbits

2000